85 donorss.
| Date | Contributor | Type | Employer | Occupation | Amount |
|---|---|---|---|---|---|
| 2026-01-31 | Sanat Chattopadhyay | IND | Merck Sharp & Dohme | EVP, Merck Manufacturing | $753.44 |
| 2026-01-31 | Eliav Barr | IND | Merck Sharp & Dohme | SVP., Clinical Research. | $752.70 |
| 2026-01-31 | David M Williams | IND | Merck Sharp & Dohme | EVP, Chief Information Officer | $596.16 |
| 2026-01-31 | David R Maraldo | IND | Merck Sharp & Dohme | SVP., Operations. | $538.46 |
| 2026-01-31 | Peter Tattle | IND | Merck Sharp & Dohme | SVP., Managing Director | $442.30 |
| 2026-01-31 | Paula W. Annunziato | IND | Merck Sharp & Dohme | SVP, Clinical Research | $440.84 |
| 2026-01-31 | Joanne H Monahan | IND | Merck Sharp & Dohme | SVP, Customer Business Line. | $430.54 |
| 2026-01-31 | Arthur J Hirt | IND | Merck Sharp & Dohme | SVP, Business Unit | $430.54 |
| 2026-01-31 | Dalton Smart III | IND | Merck Sharp & Dohme | SVP, General Accounting | $424.36 |
| 2026-01-31 | Robert Filippone | IND | Merck Sharp & Dohme | VP, Policy/Govern. Relations. | $424.34 |
| 2026-01-31 | Nicole Longo | IND | Merck Sharp & Dohme | SVP, Fin. Planning & Analysis | $417.26 |
| 2026-01-31 | Sean Curtis | IND | Merck Sharp & Dohme | SVP, Regulatory Affairs | $402.12 |
| 2026-01-31 | Susanna Webber | IND | Merck Sharp & Dohme | SVP., Procurement | $400.48 |
| 2026-01-31 | Isabel C. Duffy | IND | Merck Sharp & Dohme | SVP., Compliance Officer | $396.16 |
| 2026-01-31 | Allen Harberg | IND | Merck Sharp & Dohme | SVP, Legal | $396.16 |
| 2026-01-31 | Scott Bormann | IND | Merck Sharp & Dohme | SVP., Regional Marketing | $390.02 |
| 2026-01-31 | Jeffrey Augustin | IND | Merck Sharp & Dohme | VP, Shared Svcs Finance | $386.06 |
| 2026-01-31 | Johanna Herrmann | IND | Merck Sharp & Dohme | SVP, Global Communications | $384.62 |
| 2026-01-31 | Michael H Kress | IND | Merck Sharp & Dohme | SVP, Pharm Process Dev. | $384.60 |
| 2026-01-31 | Alema Galijatovic Idrizbegovic | IND | Merck Sharp & Dohme | VP, Preclinical Dev. | $384.60 |
| 2026-01-31 | Gary A. Henningsen Jr. | IND | Merck Sharp & Dohme | SVP, Tax | $384.60 |
| 2026-01-31 | George H. Addona | IND | Merck Sharp & Dohme | SVP., Research Science. | $384.60 |
| 2026-01-31 | Robert M Garbaccio | IND | Merck Sharp & Dohme | VP, Chemistry | $384.60 |
| 2026-01-31 | Christin L O'Neill | IND | Merck Sharp & Dohme | AVP, Market Access ONC | $384.60 |
| 2026-01-31 | Melissa Leonard | IND | Merck Sharp & Dohme | SVP, Finance | $384.60 |
| 2026-01-31 | Barry McCoy | IND | Merck Sharp & Dohme | VP, Legal | $384.60 |
| 2026-01-31 | Robert M. Davis | IND | Merck Sharp & Dohme | Chairman and Chief Executive Officer | $384.60 |
| 2026-01-31 | Craig Roberts | IND | Merck Sharp & Dohme | VP, Outcomes Research | $384.60 |
| 2026-01-31 | Jennifer Baxter | IND | Merck Sharp & Dohme | SVP, Engineering | $384.60 |
| 2026-01-31 | Jennifer Finnegan McCafferty | IND | Merck Sharp & Dohme | SVP. Regulatory Affairs | $384.60 |
| 2026-01-31 | Juan Alvarez | IND | Merck Sharp & Dohme | VP., Research Science. | $384.60 |
| 2026-01-31 | Jennifer Zachary | IND | Merck Sharp & Dohme | EVP, General Counsel | $384.60 |
| 2026-01-31 | Jeffrey B Simmons | IND | Merck Sharp & Dohme | CEO Chief of Staff | $384.60 |
| 2026-01-31 | Paula Alston | IND | Merck Sharp & Dohme | VP, Facilities | $384.60 |
| 2026-01-31 | Kathryn S Hayward | IND | Merck Sharp & Dohme | SVP, Business Unit | $384.60 |
| 2026-01-31 | Elizabeth Good | IND | Merck Sharp & Dohme | VP., HR Business Partner | $384.60 |
| 2026-01-31 | Erin James Whalen | IND | Merck Sharp & Dohme | VP., Research Science | $384.60 |
| 2026-01-31 | Betty Larson | IND | Merck Sharp & Dohme | EVP, Human Resources | $384.60 |
| 2026-01-31 | Denise Allen Williams | IND | Merck Sharp & Dohme | VP, Strategic Planning | $379.62 |
| 2026-01-31 | Lizabeth Leveille | IND | Merck Sharp & Dohme | VP., Business Development | $376.72 |
| 2026-01-31 | Jessica D Trenti | IND | Merck Sharp & Dohme | VP., HR Business Partner | $368.42 |
| 2026-01-31 | Anil Sawant | IND | Merck Sharp & Dohme | VP, Quality Assurance | $366.02 |
| 2026-01-31 | Elizabeth Liss | IND | Merck Sharp & Dohme | VP, Project Management | $353.84 |
| 2026-01-31 | Sandra Addo | IND | Merck Sharp & Dohme | VP, Audit | $352.58 |
| 2026-01-31 | James E Curotto | IND | Merck Sharp & Dohme | VP., Business Unit | $351.62 |
| 2026-01-31 | Gary E MacPhee | IND | Merck Sharp & Dohme | VP , Technology Partnership | $346.16 |
| 2026-01-31 | Breon Leigh Wood Burgess | IND | Merck Sharp & Dohme | VP, Fin. Planning & Analysis | $344.66 |
| 2026-01-31 | Terri J Lee | IND | Merck Sharp & Dohme | VP, Policy/Govern. Relations. | $344.44 |
| 2026-01-31 | Piero Fabio Magnarelli | IND | Merck Sharp & Dohme | VP, Global Marketing ONC | $335.82 |
| 2026-01-31 | James F McIntyre | IND | Merck Sharp & Dohme | VP, Business Development | $330.08 |
| 2026-01-31 | CATHERINE C ROBINSON | IND | Merck Sharp & Dohme | VP, Account Management GHH | $326.92 |
| 2026-01-31 | Michelle Braun | IND | Merck Sharp & Dohme | VP, Procurement | $324.56 |
| 2026-01-31 | Keith Cooper | IND | Merck Sharp & Dohme | VP, Procurement | $323.00 |
| 2026-01-31 | Michael G. Schwartz | IND | Merck Sharp & Dohme | VP, Fin. Planning & Analysis | $316.92 |
| 2026-01-31 | Paula Kara | IND | Merck Sharp & Dohme | VP, Tax | $316.92 |
| 2026-01-31 | Kelley J Brna | IND | Merck Sharp & Dohme | VP., Operations | $313.46 |
| 2026-01-31 | Dale Huff | IND | Merck Sharp & Dohme | VP, Supplier Dev & Perf | $309.98 |
| 2026-01-31 | Cheryl A Donnelly | IND | Merck Sharp & Dohme | VP., Global Marketing | $309.00 |
| 2026-01-31 | Tim A Mallo | IND | Merck Sharp & Dohme | VP, Quality | $298.80 |
| 2026-01-31 | Erin Lewis Darling | IND | Merck Sharp & Dohme | AVP, Policy/Govern. Relations | $286.52 |
| 2026-01-31 | Amanda M Taylor | IND | Merck Sharp & Dohme | VP, Plant Management | $282.88 |
| 2026-01-31 | Brandon Palermo | IND | Merck Sharp & Dohme | VP, Medical Affairs | $267.40 |
| 2026-01-31 | John V Faliveno | IND | Merck Sharp & Dohme | AVP, Account Management GHH | $266.94 |
| 2026-01-31 | Geoffrey A. Walford | IND | Merck Sharp & Dohme | Scientific AVP, Clinical Research | $246.60 |
| 2026-01-31 | Luther T Clark | IND | Merck Sharp & Dohme | Exec. Dir, Medical Affairs | $244.56 |
| 2026-01-31 | David D. Jones | IND | Merck Sharp & Dohme | VP, Managing Director | $242.54 |
| 2026-01-31 | Cristopher Regent | IND | Merck Sharp & Dohme | AVP, Marketing | $242.26 |
| 2026-01-31 | Matthew Paul Badalucco | IND | Merck Sharp & Dohme | Exec. Dir, Policy/Govern. Relations | $240.00 |
| 2026-01-31 | Michael A Stanton | IND | Merck Sharp & Dohme | AVP, Global Marketing | $237.28 |
| 2026-01-31 | Romulo Ferrero | IND | Merck Sharp & Dohme | VP., Global Marketing | $235.28 |
| 2026-01-31 | Alan Lipschitz | IND | Merck Sharp & Dohme | Exec. Dir., Medical Affairs | $234.30 |
| 2026-01-31 | Colette S Ranucci | IND | Merck Sharp & Dohme | VP., Engineering | $230.60 |
| 2026-01-31 | Patrick C Moore | IND | Merck Sharp & Dohme | AVP. , D&A Strategy | $228.66 |
| 2026-01-31 | Douglas A Black | IND | Merck Sharp & Dohme | AVP, Global Marketing ONC | $225.58 |
| 2026-01-31 | Carisa Stadlman De Anda | IND | Merck Sharp & Dohme | Dist. Scientist, Clinical Research | $223.92 |
| 2026-01-31 | Bradford Tallamy | IND | Merck Sharp & Dohme | Exec. Dir, Policy/Govern. Relations | $222.16 |
| 2026-01-31 | Andrew A Stratton | IND | Merck Sharp & Dohme | VP., Operations | $221.50 |
| 2026-01-31 | Nicole Salis | IND | Merck Sharp & Dohme | AVP, Marketing Comms/Channels | $216.34 |
| 2026-01-31 | George L Pla | IND | Merck Sharp & Dohme | AVP, Sales GHH | $215.76 |
| 2026-01-31 | Laura Ginkel | IND | Merck Sharp & Dohme | SVP, Legal | $209.96 |
| 2026-01-31 | Brian Smith | IND | Merck Sharp & Dohme | Exec. Dir, Policy/Govern. Relations | $205.92 |
| 2026-01-31 | Sherita P Lee | IND | Merck Sharp & Dohme | Dir., Account Management GHH | $204.44 |
| 2026-01-31 | Joanne McMahon | IND | Merck Sharp & Dohme | AVP, Regional Marketing ONC | $200.86 |
| 2026-01-31 | ROBERT STIANCHI | IND | Merck Sharp & Dohme | AVP, Regional Marketing ONC | $200.86 |
| 2026-01-20 | Subhash Gatla | IND | Merck Sharp & Dohme | Assoc. Dir. , Software Engineering | $0.00 |